Personalized Vaccines Hold Cancer at Bay in Two Early Trials

A novel class of personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials, pointing to a new way to help the immune system fight back.
Reuters Health Information

http://ift.tt/2tWwOkQ